English  |  正體中文  |  简体中文  |  Items with full text/Total items : 26988/38789
Visitors : 2312567      Online Users : 37
RC Version 4.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Adv. Search
LoginUploadHelpAboutAdminister

Please use this identifier to cite or link to this item: http://ntour.ntou.edu.tw:8080/ir/handle/987654321/27246

Title: Modulation of HER2 expression by ferulic acid on human breast cancer MCF7 cells
Authors: C. J. Chang;J. H. Chiu;L. M. Tseng;C. H. Chang;T. M. Chien;C. W. Wu;W. Y. Lui
Contributors: NTOU:Department of Food Science
國立臺灣海洋大學:食品科學系
Keywords: Cyclin D1;ERα;ferulic acid;HER2;MCF7
Date: 2006-08
Issue Date: 2011-10-21T02:24:05Z
Publisher: European Journal of Clinical Investigation
Abstract: Abstract:
Background:The molecular mechanisms underlying the mitogenic effect of ferulic acid (FA), an active compound derived from Angelica sinensis, have never been elucidated. It was the aim of this study to investigate the proliferative effect of FA on human breast cancer cell lines and to elucidate its modulation mechanism on HER2 expression in MCF7 line.
Materials and methods:By using MCF7 (oestrogen receptor-positive; ER+, HER2-low), BT474 (ER+, HER2-high), MDAMB231 (ER–, HER2-low) and SKBR3 (ER–, HER2-high) human breast cancer cell lines as in vitro models, the mitogenic effects of FA were assessed by trypan blue dye exclusion assay and DNA flow cytometry. Ferulic acid-modulated cell signalling and HER2 gene expression were evaluated in MCF7 line by Western blot and real-time RT-PCR analysis.
Results:Ferulic acid ER-dependently stimulated cell proliferation on MCF7 cells in a concentration-dependent manner. The HER2 oncogene (one of the prognostic factors of breast cancer) and ESR1 gene (oestrogen receptor-alpha; ERα) transcription were markedly up-regulated by FA treatment. Besides, HER2 signalling and its downstream molecules such as AKT and ERK1/2 were involved in FA-modulated ERα and cyclin D1 synthesis. Addition of anti-HER2 antibody, trastuzumab, abrogated FA-enhanced proliferative effect on MCF7 cells, indicated a positive feedback control for the action of HER2 in this setting. The fact that the ER antagonist blocked most of the FA-up-regulated HER2 expression, and that trastuzumab down-regulated ERα gene expression, suggested a cross-talk between ERα and HER2 signalling on MCF7 cells.
Conclusions:The authors’ conclude that FA causes human breast cancer cell proliferation by up-regulation of HER2 and ERα expression.
Relation: 36(8), pp.588–596
URI: http://ntour.ntou.edu.tw/handle/987654321/27246
Appears in Collections:[食品科學系] 期刊論文

Files in This Item:

File Description SizeFormat
index.html0KbHTML257View/Open


All items in NTOUR are protected by copyright, with all rights reserved.

 


著作權政策宣告: 本網站之內容為國立臺灣海洋大學所收錄之機構典藏,無償提供學術研究與公眾教育等公益性使用,請合理使用本網站之內容,以尊重著作權人之權益。
網站維護: 海大圖資處 圖書系統組
DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback